eFFECTOR Therapeutics Inc.

10/07/2021 | Press release | Distributed by Public on 10/07/2021 14:33

Baylor College of Medicine Presents eFFECTOR Therapeutics-Backed Preclinical Data Supporting Development of Zotatifin in Triple-Negative Breast Cancer at 2021 AACR-NCI-EORTC[...]